At the last check on Thursday, Applied Molecular Transport Inc.’s (NASDAQ:AMTI) stock traded at $0.21. The average number of shares traded per day over the past five days has been 4,430,291 shares. 3 times new highs have been achieved over the past 5 days, with a -$0.0077 fall in that time frame. In the last twenty days, the average volume was 2,604,158, while in the previous 50 days, it was 1,082,317.
Since last month, AMTI stock retreated -25.58%. Shares of the company fell to $0.1808 on 09/01/23, the lowest level in the past month. A 52-week high of $1.39 was reached on 02/23/23 after having rallying from a 52-week low of $0.18. Since the beginning of this year, AMTI’s stock price has dropped by -49.79% or -$0.2099, and marked a new high 9 times. However, the stock has declined by -84.83% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
AMTI stock investors should be aware that Applied Molecular Transport Inc. (AMTI) stock had its last reported insider trading activity 204 days ago on Mar 01. Mahmood Tahir Ph.D., the Chief Executive Officer of the company, disposed of 1,802 shares for $0.50 on Mar 01. It resulted in a $901 divestment by the insider. Cross Shawn sold 934 shares at an average price of $0.50 on Mar 01. The insider now owns 60,156 shares following the transaction. On Mar 01, Chief Medical Officer Kanwar Bittoo sold 539 shares at $0.50 apiece. The transaction was valued at $270.
Financial Health
In the three months ended June 29, Applied Molecular Transport Inc.’s quick ratio stood at 6.10, while its current ratio was 6.10, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.01, and the total debt-to-equity ratio was 0.01.
While analysts expected Applied Molecular Transport Inc. to report $0.77 quarterly earnings, the actual figure was -$0.44 per share, beating the consensus estimate by -157.10%. The liabilities of Applied Molecular Transport Inc. were 4.31 million at the end of its most recent quarter ended June 29, and its total debt was $1.71 million. The value of shareholders’ equity is $39.43 million.
Technical Picture
This quick technical analysis looks at Applied Molecular Transport Inc.’s (AMTI) price momentum. With a historical volatility rate of 75.28%, the RSI 9-day stood at 45.21% on 20 September.
With respect to its five-day moving average, the current Applied Molecular Transport Inc. price is down by -3.54% percent or -$0.0077. At present, AMTI shares trade -27.55% below its 20-day simple moving average and -28.66% percent below its 100-day simple moving average. However, the stock is currently trading approximately -34.34% below its SMA50 and -82.19% below its SMA200.
Stochastic coefficient K was 10.65% and Stochastic coefficient D was 10.74%, while ATR was 0.0435. Given the Stochastic reading of 12.78% for the 14-day period, the RSI (14) reading has been calculated as 43.40%.
Analyst Ratings
JMP Securities launched its rating on Applied Molecular Transport Inc. (NASDAQ: AMTI) to a Mkt outperform in a note to investors on March 17, 2021. Applied Molecular Transport Inc. (AMTI) has been rated Hold by analysts. According to 0 brokerage firms, AMTI is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Applied Molecular Transport Inc. stock as buy, with 0 recommending it as overweight.
With a median target price of $1.00, the current consensus forecast for the stock is $1.00 – $1.00. Based on these forecasts, analysts predict Applied Molecular Transport Inc. (AMTI) will achieve an average price target of $1.00.
